Benign/Malignant Pulmonary Nodule Classification Based on High-throughput Whole-genome Methylation Sequencing(GM-seq)

Clinical trial NCT05415670 · COMPLETED

Trial details

NCT number: NCT05415670
Sponsor: Geneplus-Beijing Co. Ltd.
Status: COMPLETED
Study type: OBSERVATIONAL

Pulmonary Nodule, Solitary Whole-genome Methylation Sequencing

Start date: 2023-07-01
Primary completion: 2025-06-01
Enrollment: 158

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.